OrthoPediatrics (NASDAQ:KIDS) Shares Down 3.5% Following Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report)'s share price fell 3.5% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $24.48 and last traded at $24.54. 22,235 shares were traded during trading, a decline of 86% from the average session volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $133,224.74. Following the sale, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. The trade was a 3.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Fred Hite sold 6,443 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $160,172.98. Following the completion of the transaction, the chief financial officer now owns 207,989 shares of the company's stock, valued at approximately $5,170,606.54. This represents a 3.00 % decrease in their position. The disclosure for this sale can be found here. In other news, CEO David R. Bailey sold 6,620 shares of OrthoPediatrics stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the sale, the chief executive officer now directly owns 319,155 shares in the company, valued at approximately $7,934,193.30. The trade was a 2.03 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts have issued reports on KIDS shares. Needham & Company LLC reiterated a "buy" rating and set a $42.00 price objective on shares of OrthoPediatrics in a research note on Wednesday, March 5th. Truist Financial dropped their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a research report on Wednesday, December 18th. Finally, Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research report on Wednesday, March 5th.

OrthoPediatrics Trading Down 2.2 %

The company has a 50-day simple moving average of $24.85 and a 200-day simple moving average of $25.45. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market cap of $606.45 million, a P/E ratio of -20.30 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.04. The firm had revenue of $52.67 million during the quarter, compared to analysts' expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter in the previous year, the company posted ($0.23) EPS. On average, sell-side analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Institutional Investors Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently modified their holdings of KIDS. Quarry LP bought a new position in OrthoPediatrics in the third quarter valued at approximately $25,000. R Squared Ltd bought a new position in shares of OrthoPediatrics in the 4th quarter worth $48,000. KLP Kapitalforvaltning AS acquired a new stake in shares of OrthoPediatrics during the fourth quarter worth $79,000. BNP Paribas Financial Markets grew its stake in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock worth $94,000 after purchasing an additional 1,929 shares during the period. Finally, Quantbot Technologies LP increased its holdings in OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company's stock valued at $157,000 after purchasing an additional 1,712 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.